Wikimedia Commons

A worker ant carries a leaf.

Takeovers of drugmakers have reached record volumes in 2015, and Centerview Partners has been cashing in big.

The boutique, started in 2006 by Blair Effron has racked up $ 270 million or so in deal fees relating to pharmaceuticals and healthcare, according to consulting firm Freeman & Co.

That only accounts for deals that have closed. Centerview added another $ 20 million to $ 25 million to that haul on Monday, by advising US biotech Dyax on its sale to Shire. 

As a result, the bank is making a run on the biggest advisors in the industry. 

In the US Healthcare M&A league tables, we actually have Centerview ranked #3, behind only Goldman and JPMorgan,” says Jeffrey Nassof, vice president with Freeman & Co.

Centerview ranked third, last year, according to Freeman & Co. and fourth in 2013.

Nassof went on to say that, counting deals like Dyax, Centerview’s total haul just for healthcare and pharma advisory for the year will likely surpass the $ 300 million mark. 

Here is a quick sampling of Centerview’s biggest deals in the sector, according to Freeman & Co. estimates: 

  • In August, Celgene’s $ 7.2 billion deal to buy out biotech firm Receptos netted Centerview a payday of about $ 55 million — this, thanks to its being the exclusive advisor on the deal. 
  • Centerview split the advisory role (and, fees) with JPMorgan when Valeant spent $ 16 billion to buy Salix Pharmaceuticals. It was worth $ 48 million to the boutique bank. 
  • Centerview and JPMorgan again split the role advising Pharmacyclics in its $ 20 billion sale to Abbvie. That deal generated about $ 41  million in fees for Centerview. 

NOW WATCH: Everyday phrases that even smart people say incorrectly

Please enable Javascript to watch this video

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>